InvestorsHub Logo
Followers 104
Posts 2500
Boards Moderated 0
Alias Born 12/02/2016

Re: StoptheInsanity9 post# 46563

Friday, 11/17/2017 11:30:32 AM

Friday, November 17, 2017 11:30:32 AM

Post# of 94948
Aah but what you are missing is that GW Pharma started out as a biotechnology company without any revenues in sight, just like $TXTM / Protext Pharma.

Here is where it all changed for GW Pharma -- it's when the company was issued a license to research the uses of cannabis as a medicine:

https://www.gwpharm.com/about-us/news/home-office-licenses-research-medical-uses-cannabis

JUN 11, 1998
The Home Office has issued a licence for a British pharmaceuticals company to investigate the uses of cannabis as a medicine.

GW Pharmaceuticals, founded by Dr Geoffrey Guy, has been licensed under the Misuse of Drugs Act 1971 to proceed with a complete pharmaceutical research and development programme into cannabis and its chemical compounds, and in particular into delivery methods other than smoking. The objectives of the research and development programme will be:

initially to develop standardised extracts of cannabis sativa (the most common cannabis plant), specially grown under controlled conditions.
to establish the best delivery method into patients - other than smoking - of cannabis and/or its constituents, and to establish if safe therapeutic uses exist in a range of illnesses.
to provide materials for clinical trials and extended monitoring programmes.
to prepare data for Product Licence Approval by the Medicine Controls Agency.
to expand the programme internationally with academic researchers and pharmaceutical partners.
eventually to identify purified fractions and/or subsets including single entities, which may have useful therapeutic applications or can serve as research tools.
All work will be carried out at secure research facilities in the UK.